vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and ZILLOW GROUP, INC. (ZG). Click either name above to swap in a different company.

ZILLOW GROUP, INC. is the larger business by last-quarter revenue ($654.0M vs $487.7M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). ZILLOW GROUP, INC. runs the higher net margin — 0.5% vs -10.1%, a 10.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 18.1%). ZILLOW GROUP, INC. produced more free cash flow last quarter ($44.0M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 11.2%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Zillow Group, Inc., or simply Zillow, is an American tech real-estate marketplace company that was founded in 2006 by co-executive chairmen Rich Barton and Lloyd Frink, former Microsoft executives and founders of Microsoft spin-off Expedia; Spencer Rascoff, a co-founder of Hotwire.com; David Beitel, Zillow's current chief technology officer; and Kristin Acker, Zillow's current technology leadership advisor.

CLOV vs ZG — Head-to-Head

Bigger by revenue
ZG
ZG
1.3× larger
ZG
$654.0M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+26.7% gap
CLOV
44.7%
18.1%
ZG
Higher net margin
ZG
ZG
10.6% more per $
ZG
0.5%
-10.1%
CLOV
More free cash flow
ZG
ZG
$113.0M more FCF
ZG
$44.0M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
11.2%
ZG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
ZG
ZG
Revenue
$487.7M
$654.0M
Net Profit
$-49.3M
$3.0M
Gross Margin
72.8%
Operating Margin
-10.1%
-1.7%
Net Margin
-10.1%
0.5%
Revenue YoY
44.7%
18.1%
Net Profit YoY
-123.2%
105.8%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
ZG
ZG
Q4 25
$487.7M
$654.0M
Q3 25
$496.6M
$676.0M
Q2 25
$477.6M
$655.0M
Q1 25
$462.3M
$598.0M
Q4 24
$337.0M
$554.0M
Q3 24
$331.0M
$581.0M
Q2 24
$356.3M
$572.0M
Q1 24
$346.9M
$529.0M
Net Profit
CLOV
CLOV
ZG
ZG
Q4 25
$-49.3M
$3.0M
Q3 25
$-24.4M
$10.0M
Q2 25
$-10.6M
$2.0M
Q1 25
$-1.3M
$8.0M
Q4 24
$-22.1M
$-52.0M
Q3 24
$-9.2M
$-20.0M
Q2 24
$7.4M
$-17.0M
Q1 24
$-19.2M
$-23.0M
Gross Margin
CLOV
CLOV
ZG
ZG
Q4 25
72.8%
Q3 25
72.6%
Q2 25
74.7%
Q1 25
76.8%
Q4 24
75.8%
Q3 24
24.5%
75.9%
Q2 24
30.3%
77.3%
Q1 24
23.6%
76.7%
Operating Margin
CLOV
CLOV
ZG
ZG
Q4 25
-10.1%
-1.7%
Q3 25
-4.9%
-0.4%
Q2 25
-2.2%
-1.7%
Q1 25
-0.3%
-1.5%
Q4 24
-6.4%
-12.5%
Q3 24
-2.7%
-7.7%
Q2 24
2.0%
-6.6%
Q1 24
-6.5%
-8.5%
Net Margin
CLOV
CLOV
ZG
ZG
Q4 25
-10.1%
0.5%
Q3 25
-4.9%
1.5%
Q2 25
-2.2%
0.3%
Q1 25
-0.3%
1.3%
Q4 24
-6.6%
-9.4%
Q3 24
-2.8%
-3.4%
Q2 24
2.1%
-3.0%
Q1 24
-5.5%
-4.3%
EPS (diluted)
CLOV
CLOV
ZG
ZG
Q4 25
$0.01
Q3 25
$0.04
Q2 25
$0.01
Q1 25
$0.03
Q4 24
$-0.23
Q3 24
$-0.08
Q2 24
$-0.07
Q1 24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
ZG
ZG
Cash + ST InvestmentsLiquidity on hand
$78.3M
$768.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$4.9B
Total Assets
$541.0M
$5.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
ZG
ZG
Q4 25
$78.3M
$768.0M
Q3 25
$874.0M
Q2 25
$587.0M
Q1 25
$914.0M
Q4 24
$194.5M
$1.1B
Q3 24
$288.0M
$1.1B
Q2 24
$254.8M
$1.2B
Q1 24
$208.3M
$1.4B
Stockholders' Equity
CLOV
CLOV
ZG
ZG
Q4 25
$308.7M
$4.9B
Q3 25
$340.9M
$5.0B
Q2 25
$344.2M
$4.7B
Q1 25
$336.1M
$4.8B
Q4 24
$341.1M
$4.8B
Q3 24
$342.2M
$4.7B
Q2 24
$324.9M
$4.5B
Q1 24
$292.5M
$4.7B
Total Assets
CLOV
CLOV
ZG
ZG
Q4 25
$541.0M
$5.7B
Q3 25
$559.7M
$5.7B
Q2 25
$575.0M
$5.4B
Q1 25
$583.7M
$5.7B
Q4 24
$580.7M
$5.8B
Q3 24
$653.0M
$6.2B
Q2 24
$674.2M
$6.6B
Q1 24
$671.8M
$6.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
ZG
ZG
Operating Cash FlowLast quarter
$-66.9M
$72.0M
Free Cash FlowOCF − Capex
$-69.0M
$44.0M
FCF MarginFCF / Revenue
-14.1%
6.7%
Capex IntensityCapex / Revenue
0.4%
4.3%
Cash ConversionOCF / Net Profit
24.00×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$235.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
ZG
ZG
Q4 25
$-66.9M
$72.0M
Q3 25
$12.1M
$105.0M
Q2 25
$5.4M
$87.0M
Q1 25
$-16.3M
$104.0M
Q4 24
$34.8M
$122.0M
Q3 24
$50.0M
$171.0M
Q2 24
$44.8M
$55.0M
Q1 24
$25.9M
$80.0M
Free Cash Flow
CLOV
CLOV
ZG
ZG
Q4 25
$-69.0M
$44.0M
Q3 25
$11.4M
$73.0M
Q2 25
$4.8M
$50.0M
Q1 25
$-16.5M
$68.0M
Q4 24
$33.3M
$88.0M
Q3 24
$49.6M
$138.0M
Q2 24
$44.4M
$18.0M
Q1 24
$25.5M
$41.0M
FCF Margin
CLOV
CLOV
ZG
ZG
Q4 25
-14.1%
6.7%
Q3 25
2.3%
10.8%
Q2 25
1.0%
7.6%
Q1 25
-3.6%
11.4%
Q4 24
9.9%
15.9%
Q3 24
15.0%
23.8%
Q2 24
12.5%
3.1%
Q1 24
7.3%
7.8%
Capex Intensity
CLOV
CLOV
ZG
ZG
Q4 25
0.4%
4.3%
Q3 25
0.1%
4.7%
Q2 25
0.1%
5.6%
Q1 25
0.0%
6.0%
Q4 24
0.5%
6.1%
Q3 24
0.1%
5.7%
Q2 24
0.1%
6.5%
Q1 24
0.1%
7.4%
Cash Conversion
CLOV
CLOV
ZG
ZG
Q4 25
24.00×
Q3 25
10.50×
Q2 25
43.50×
Q1 25
13.00×
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

ZG
ZG

Residential Revenue$418.0M64%
Rental Revenue$168.0M26%
Mortgage Revenue$57.0M9%
Display Advertising And Other Revenue$11.0M2%

Related Comparisons